Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15535721 | 0.78 | MAOA (0.39) | MAOAMAOBMEN1GAAKMT2A | |
| SCHEMBL4563908 | 0.77 | MEN1 (0.35) | MEN1GAAKMT2ACYP2D6 | |
| SCHEMBL28742878 | 0.74 | MAOA (0.41) | MAOAMAOBMEN1KMT2AHTR2A | |
| SCHEMBL12629758 | 0.74 | MAOA (0.37) | MAOAMAOBMEN1KMT2AHTR2A | |
| SCHEMBL24475199 | 0.74 | MEN1 (0.33) | MEN1GAAKMT2AHTR2A | |
| SCHEMBL17343612 | 0.74 | MEN1 (0.38) | MEN1GAAKMT2AHTR2A | |
| SCHEMBL680551 | 0.74 | MEN1 (0.38) | MEN1GAAKMT2AHTR2A | |
| SCHEMBL680550 | 0.74 | MEN1 (0.38) | MEN1GAAKMT2AHTR2A | |
| SCHEMBL30181026 | 0.74 | MEN1 (0.38) | MEN1GAAKMT2AHTR2A | |
| SCHEMBL6237164 | 0.74 | MEN1 (0.33) | MEN1GAAKMT2AHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2478018-B1 | MAGNESIUM DICHLORIDE-ALCOHOL ADDUCTS AND CATALYST COMPONENTS OBTAINED | BASELL POLIOLEFINE SRL (IT) | 2015-01-21 | — | — | EP | claimed |
| US-5811294-A | Production of optically active 1,2-dihydroxyindance derivatives by asymetric assimilation | ZENECA LIMITED (GB) | 1998-09-22 | — | — | US | claimed |
| EP-4463534-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | The Procter & Gamble Company (US) | 2024-11-20 | — | — | EP | disclosed |
| CN-115583874-B | Method for catalyzing asymmetric tandem reaction of internal alkyne by rhodium metal | 南京林业大学 | 2024-05-28 | — | — | CN | disclosed |
| WO-2023137409-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | THE PROCTER & GAMBLE COMPANY (US) | 2023-07-20 | — | — | WO | disclosed |
| US-20230220300-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | THE PROCTER & GAMBLE COMPANY | 2023-07-13 | — | — | US | disclosed |
| US-10000703-B2 | Catalytic fast pyrolysis process | ANELLOTECH, INC. (US) | 2018-06-19 | — | — | US | disclosed |
| US-20160326438-A1 | CATALYTIC FAST PYROLYSIS PROCESS | ANELLOTECH, INC. | 2016-11-10 | — | — | US | disclosed |
| CN-102595886-A | Pesticidal compositions comprising 4,5-dihydroxyindan-1-one | YISSUM RES DEV CO | 2012-07-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230220300-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | BCAT2, MTR, ASNS | MAOA 288/4885MAOB 791/4885MEN1 1094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.